Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Longitudinal analysis of pancreatic adenocarcinoma development reveals transient gene expression signatures (I. 10-22 cell RNA-Seq)

ABSTRACT: Longitudinal analysis of pancreatic adenocarcinoma development reveals transient gene expression signatures (I. 10-22 cell RNA-Seq)

PROVIDER: PRJNA725824 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14343825.fastq.gz	Fastqsanger.gz
	SRR14343826.fastq.gz	Fastqsanger.gz
	SRR14343827.fastq.gz	Fastqsanger.gz
	SRR14343828.fastq.gz	Fastqsanger.gz
	SRR14343829.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

Longitudinal analysis of pancreatic adenocarcinoma development reveals transient gene expression signatures

Project description:Longitudinal analysis of pancreatic adenocarcinoma development reveals transient gene expression signatures

| PRJNA725124 | ENA

Longitudinal analysis of pancreatic adenocarcinoma development reveals transient gene expression signatures

Project description:We performed a transcriptome time-course analysis of genetically tagged human PDAC cells reprogrammed into a pluripotent stem cell-like line (10-22 cells) through the progression from PanINs to PDAC in mice. The results were validated using the Cancer Genome Atlas (TCGA) PDAC dataset, human clinical PanIN/PDAC tissues, and well-established murine PDAC model. Human normal pancreatic ductal epithelial cell line (H6C7) and PDAC cell lines (Miapaca2, Aspc1) are used for functional validation of HBP1. Pathways for extracellular vesicle transport pathways and neuronal cell differentiation were derepressed in the progression of PanINs to PDAC. Analysis of transcription factor (TF) motifs at dynamically expressed genes revealed roles for HBP1 and BACH during PDAC progression and their inverse correlations with PDAC patients' prognosis. Notably, we detected gene activity changes that were transient during PDAC progression. Our longitudinal analysis provides insights into networks underlying PDAC progression and pathogenesis.

2022-04-01 | GSE173286 | GEO

Longitudinal analysis of pancreatic adenocarcinoma development reveals transient gene expression signatures (I. 10-22 cell RNA-Seq)

Project description:We performed a transcriptome time-course analysis of genetically tagged 10-22 cells through the progression from PanINs to PDAC in mice. The results were validated using the Cancer Genome Atlas (TCGA) PDAC dataset, human clinical PanIN/PDAC tissues, and well-established murine PDAC model.

2022-04-01 | GSE173489 | GEO

Ito2019 - gefitnib resistance of lung adenocarcinoma caused by MET amplification

Project description:The model is based on publication: Mathematical analysis of gefitinib resistance of lung adenocarcinoma caused by MET amplification Abstract: Gefitinib, one of the tyrosine kinase inhibitors of epidermal growth factor receptor (EGFR), is effective for treating lung adenocarcinoma harboring EGFR mutation; but later, most cases acquire a resistance to gefitinib. One of the mechanisms conferring gefitinib resistance to lung adenocarcinoma is the amplification of the MET gene, which is observed in 5–22% of gefitinib-resistant tumors. A previous study suggested that MET amplification could cause gefitinib resistance by driving ErbB3-dependent activation of the PI3K pathway. In this study, we built a mathematical model of gefitinib resistance caused by MET amplification using lung adenocarcinoma HCC827-GR (gefitinib resistant) cells. The molecular reactions involved in gefitinib resistance consisted of dimerization and phosphorylation of three molecules, EGFR, ErbB3, and MET were described by a series of ordinary differential equations. To perform a computer simulation, we quantified each molecule on the cell surface using flow cytometry and estimated unknown parameters by dimensional analysis. Our simulation showed that the number of active ErbB3 molecules is around a hundred-fold smaller than that of active MET molecules. Limited contribution of ErbB3 in gefitinib resistance by MET amplification is also demonstrated using HCC827-GR cells in culture experiments. Our mathematical model provides a quantitative understanding of the molecular reactions underlying drug resistance.

2024-09-02 | BIOMD0000000827 | BioModels

Panicum virgatum cultivar:SAP-22-10

Project description:Panicum virgatum exome capture - SAP-22-10

| PRJNA447786 | ENA

Neisseria gonorrhoeae strain:20/22/10

Project description:Neisseria gonorrhoeae strain:20/22/10 Genome sequencing

| PRJNA1097269 | ENA

Epigenetic analysis of normal colon epithelium and colon adenocarcinoma

Project description:Genome-wide DNA methylation profiles were obtained from colon adenocarcinoma samples (22), corresponding normal colon tissue (22) and cancer-unrelated normal colon tissue using Illumina HumanMethylation450 BeadChips. Approximately 485000 CpG sites were measured in every sample.

2012-12-06 | GSE42752 | GEO

Genotyping of paired samples of normal colon and colon adenocarcinoma to estimate copy-number alterations

Project description:22 pairs of normal colon\colon adenocarcinoma samples were genotyped using Illumina HumanOmni1-Quad BeadChip to estimate copy number alterations Genomic DNA of 22 colon adenocarcinoma samples and 22 corresponding normal colon samples were genotyped using Illumina HumanOmni1-Quad BeadChip to estimate copy number alterations.

2013-02-01 | E-GEOD-43933 | biostudies-arrayexpress

Bradyrhizobium japonicum 22 strain:22

Project description:Bradyrhizobium japonicum 22 strain:22 Genome sequencing and assembly

| PRJNA195878 | ENA

Gene expression signatures for lung adenocarcinoma

Project description:Gene expression signatures for lung adenocarcinoma

| PRJNA590980 | ENA